AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Price Up 4.4% – Should You Buy?

AdvisorShares Psychedelics ETF (NYSEARCA:PSILGet Free Report)’s stock price were up 4.4% on Thursday . The company traded as high as $23.00 and last traded at $22.67. 56,502 shares were traded during trading, an increase of 93% from the average daily volume of 29,218 shares. The stock had previously closed at $21.72.

AdvisorShares Psychedelics ETF Stock Up 4.4%

The business’s fifty day simple moving average is $20.24 and its 200-day simple moving average is $18.35.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in AdvisorShares Psychedelics ETF stock. CIBC Private Wealth Group LLC lifted its position in AdvisorShares Psychedelics ETF (NYSEARCA:PSILFree Report) by 18.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,566 shares of the company’s stock after purchasing an additional 4,547 shares during the quarter. CIBC Private Wealth Group LLC owned about 2.51% of AdvisorShares Psychedelics ETF worth $508,000 at the end of the most recent reporting period.

AdvisorShares Psychedelics ETF Company Profile

(Get Free Report)

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.

Featured Articles

Receive News & Ratings for AdvisorShares Psychedelics ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and related companies with MarketBeat.com's FREE daily email newsletter.